Insiders VolitionRx Limited

Equities

VNRX

US9286611077

Market Closed - Nyse Other stock markets 21:10:00 10/05/2024 BST			5-day change	1st Jan Change
0.829 ^USD	+2.36%		-6.95%	+15.62%

04-26	VolitionRx Limited Announces Board Changes	CI
04-23	VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VolitionRx Limited Announces Board Changes	04-26	CI
VolitionRx Names Andrew Retter as Chief Medical Officer	03-19	MT
Volitionrx Limited Appoints Andrew Retter as Chief Medical Officer, Effective April 1, 2024	03-19	CI
Insider Buy: Volitionrx	19/12/22	MT
Volitionrx Limited Announces Resignation of Dr. Jason Terrell as Chief Medical Officer	25/11/22	CI
VolitionRx Limited Appoints Mickie Henshall as Independent Director	16/08/22	CI
VolitionRx Limited Appoints Sharon Ballesteros as U.S. Head of Quality and Development Process	06/04/22	CI
Insider Trends: VolitionRX Insider 90-Day Buying Trend Prolonged with Purchase	18/05/21	MT
VolitionRx Limited Announces Executive Changes, Effective May 1, 2021	30/03/21	CI
VolitionRx Limited Announces Resignation of Salvatore Thomas Butera from the Board and from the Audit Committee, Compensation Committee and Nominations and Governance Committee	29/03/21	CI
VolitionRx Limited Appoints Two New Directors	29/03/21	CI
VolitionRx Limited Appoints Terig Hughes as Chief Financial Officer	02/02/21	CI
Volitionrx Limited Announces Executive Appointments	02/02/21	CI
VolitionRx Limited Appoints Dr. Tom Butera DVM to its Board of Directors, Audit, Compensation and Nominations and Governance Committees	03/12/20	CI
VolitionRx Limited Appoints Phillip Barnes to Board of Directors, Effective October 9, 2019	09/10/19	CI
VolitionRx Limited Forms Texas-Based Veterinary Subsidiary; Appoints Nathan Dewsbury its Chief Executive Officer	08/08/19	CI
VolitionRx Limited Appoints Dr. Lee-Jen Wei to Its Scientific Advisory Board	07/03/18	CI
VolitionRx Limited Announces the Formation of Volition America, Inc; Announces Appointment to Volition America	20/03/17	CI
VolitionRx Limited Appoints Jasmine Kway as Vice President of Asia	05/01/17	CI
VolitionRX Ltd. Announces Management Changes	06/12/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders VolitionRx Limited

Equities

VNRX

US9286611077

Insiders

Filters